RxDoctor Payments Data

Jeffrey Schiff, MD

Urology · Garden City, NYNPI 1568668937

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $144,438 of the $198,461 with a category attached, or 72.8%. Teleflex LLC accounts for 92.8% of it on its own, with 10 other manufacturers making up the rest. Reporting peaked in 2023 at $93,708 and has fallen 72.7% since, to $25,555 in 2025. Among urology clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$198,461in general payments, 2019–2025

Across 305 payments — averaging $650.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Teleflex LLC$184K
  • Neotract Inc.$10K
  • Procept Biorobotics Corporation$3K
  • EDAP Technomed Inc$870
  • Boston Scientific$418
  • Axonics, Inc.$211
  • plus $525 from 5 others

What the payments were for

  • Consulting fees$33,67517%
  • Speaking & faculty fees$144,43873%
  • Travel & lodging$9,8735%
  • Food & beverage$10,4005%
  • Education$750%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$198,461 in reported general payments places this provider in the 95th percentile of 952 urology providers in New York.

See all urology providers in New York

Medicare billing

Part B allowed, 2024
$1,033,174
Medicare patients
1,485
Services billed
25,033

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MyrbetriqMirabegron121$83,258
Tamsulosin Hcl807$11,638
Silodosin105$9,500
GemtesaVibegron11$9,086
Mirabegron ErMirabegron14$5,211
Alfuzosin Hcl ErAlfuzosin Hcl234$4,928
Solifenacin Succinate25$4,001
Oxybutynin Chloride ErOxybutynin Chloride100$2,791
Tadalafil37$2,722
Tolterodine Tartrate ErTolterodine Tartrate26$1,511
Fesoterodine Fumarate ErFesoterodine Fumarate13$1,211
Dutasteride28$1,146
Methenamine Hippurate19$1,112
Potassium Citrate ErPotassium Citrate17$1,098
Finasteride87$929

Paid to pharmacies, not to this prescriber.

Other urology in Garden City

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →